|
|
MLN2704 An immunoconjugate that consists of a humanized monoclonal antibody (MLN591), directed against prostate-specific membrane antigen linked to a maytansinoid (DM1). The monoclonal antibody moiety of MLN2704 binds to tumor cells expressing prostate-specific membrane antigen; MLN274 is then internalized into the tumor cell where the DM1 maytansinoid moiety binds to tubulin and inhibits tubulin polymerization and microtubule assembly, resulting in a disruption of microtubule activity and cell division, and cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms: | | DM1-conjugated monoclonal antibody MLN591 maytansinoid -1 conjugated with MLN591 monoclonal antibody | | | Code name: | | MLN591DM1 | | |
|
|